Amany S. Mostafa

Amany S. Mostafa

Auto-generated profile, based on publicly available information

Amany S. Mostafa

Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy Mansoura University Mansoura Egypt

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2023 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
DODina I. A. Othman
Dina I. A. Othman
AHAbdelrahman Hamdi
Abdelrahman Hamdi
STSamar S. Tawfik
Samar S. Tawfik
AEAbdullah Elgazar
Abdullah Elgazar
AMAmany S. Mostafa
Amany S. Mostafa
Multi-target inhibitors represent useful anticancer agents with superior therapeutic attributes. Here in, two novel series of benzimidazole-triazole hybrids were designed, synthesised as multi-target EGFR, VEGFR-2 and Topo II inhibitors, and evaluated for anticancer activity. Compounds 5a and 6g were the most potent analogues against four cancer cell lines, HepG-2, HCT-116, MCF-7 and HeLa, and were further evaluated for EGFR, VEGFR-2, and Topo II inhibition. Compound 5a was especially good inhibitor for EGFR (IC50 = 0.086 µM) compared to Gefitinib (IC50 = 0.052 µM), moderate VEGFR-2 inhibitor (IC50 = 0.107 µM) compared to Sorafenib (IC50 = 0.0482 µM), and stronger Topo II inhibitor (IC50 = 2.52 µM) than Doxorubicin (IC50 = 3.62 µM). Compound 6g exhibited moderate EGFR and VEGFR-2 inhibition and weaker Topo II inhibition. DNA binding assay, cell cycle analysis, apoptotic induction, molecular docking, and physicochemical studies were additionally implemented to explore the plausible mechanism of the active compounds. GRAPHICAL ABSTRACT

1 April 2019 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MZMohamed A. Zeidan
Mohamed A. Zeidan
AMAmany S. Mostafa
Amany S. Mostafa
RGRania M. Gomaa
Rania M. Gomaa
LALaila A. Abou-Zeid
Laila A. Abou-Zeid
MEMohamed El-Mesery
Mohamed El-Mesery
KSKhalid B. Selim
Khalid B. Selim

1 August 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AMAmany S. Mostafa
Amany S. Mostafa
KSKhalid B. Selim
Khalid B. Selim

4 November 2018 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
AMAmany S. Mostafa
Amany S. Mostafa
RGRania M. Gomaa
Rania M. Gomaa
MEMohammad A. Elmorsy
Mohammad A. Elmorsy

19 August 2022 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
AAAlaa M. Ali
Alaa M. Ali
STSamar S. Tawfik
Samar S. Tawfik
AMAmany S. Mostafa
Amany S. Mostafa
MMMohammed A. M. Massoud
Mohammed A. M. Massoud

13 May 2019 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
ENEman E. Nasr
Eman E. Nasr
AMAmany S. Mostafa
Amany S. Mostafa
MEMagda Abd Elaziz Elsayed
Magda Abd Elaziz Elsayed
MMMohammed A. M. Massoud
Mohammed A. M. Massoud